XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.2
SHARE-BASED AWARDS AND STOCK OPTIONS (Tables)
9 Months Ended
Sep. 30, 2021
Share-based Payment Arrangement [Abstract]  
Schedule of Allocation of Share-Based Compensation Costs by Plan
The following table summarizes share-based compensation expense and the related income tax benefit recognized for our share-based awards and stock options:
Three Months EndedNine Months Ended
September 30, 2021September 30, 2020September 30, 2021September 30, 2020
(in thousands)(in thousands)
Share-based compensation expense$65,611 $42,276 $146,097 $105,081 
Income tax benefit$16,224 $9,123 $34,595 $23,338 
Schedule of Changes in Non-Vested Restricted Stock Awards Activity
The following table summarizes the changes in unvested restricted stock and performance awards for the nine months ended September 30, 2021:
SharesWeighted-Average
Grant-Date
Fair Value
(in thousands)
Unvested at December 31, 20201,546 $176.71 
Granted1,437 193.59 
Vested(1,162)153.99 
Forfeited(90)180.76 
Unvested at September 30, 20211,731 $183.74 
Schedule of Stock Option Activity
The following table summarizes stock option activity for the nine months ended September 30, 2021: 
OptionsWeighted-Average Exercise PriceWeighted-Average Remaining Contractual TermAggregate Intrinsic Value
(in thousands)(years)(in millions)
Outstanding at December 31, 20201,253 $93.66 6.3$152.6
Granted112 196.06 
Forfeited(1)113.48 
Exercised(181)69.08 
Outstanding at September 30, 20211,183 $106.98 6.0$69.4
Options vested and exercisable at September 30, 2021908 $86.45 5.3$66.4
Schedule of Stock Option Valuation Assumptions Fair value was estimated on the date of grant using the Black-Scholes valuation model with the following weighted-average assumptions:
Nine Months Ended
September 30, 2021September 30, 2020
Risk-free interest rate0.59%1.24%
Expected volatility40%30%
Dividend yield0.44%0.39%
Expected term (years)55